F-18-FDG-PET zur Primärdiagnostik und Dignitätsbeurteilung pleuraler Prozesse

I Buchmann; C A Guhlmann; K Elsner; W Gfrörer; H Schirrmeister; J Kotzerke; A Buck; S N Reske

F-18-FDG-PET zur Primärdiagnostik und Dignitätsbeurteilung pleuraler Prozesse

Translated title of the contribution: F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes

I Buchmann, C A Guhlmann, K Elsner, W Gfrörer, H Schirrmeister, J Kotzerke, A Buck, S N Reske

Clinic of Radiology and Nuclear Medicine

24 Citations (Scopus)

Abstract

PURPOSE: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) has been shown to be accurate for differentiating benign from malignant pulmonary lesions. Therefore, we evaluated the capability of FDG-PET in the characterisation of pleural lesions.

PATIENTS AND METHODS: PET was performed in thirteen patients with pleural or intrapulmonal tumors (three with additional pleural effusion) and in three patients with aetiologically unclear pleural effusion demonstrated by CT. In all cases the diagnosis was confirmed histologically. The PET-imaging was carried out in fasted patients 50 minutes after injection of 400-670 MBq F-18-FDG without attenuation correction.

RESULTS: Twelve patients were found to have pleural or pulmonal malignomas (9 pleural mesotheliomas, 3 bronchogenic adenocarcinoma with carcinomatous pleurisy). Four patients had benign pleural changes (1 fibroma, 1 tuberculous pleurisy, 1 pleural fibrosis, 1 empyema). With FDG-PET, all 12 pleural or intrapulmonal malignomas had high FDG-uptake and were classified correctly. Due to very low or virtually deficient FDG-uptake, four histologically benign lesions were correctly interpreted as nonmalignant.

CONCLUSION: These preliminary results suggest that FDG-PET is accurate in detecting malignant pleural tumors.

Translated title of the contribution	F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes
Original language	German
Journal	NuklearMedizin
Volume	38
Issue number	8
Pages (from-to)	319-22
Number of pages	4
ISSN	0029-5566
Publication status	Published - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 9 Industry, Innovation, and Infrastructure

Cite this

@article{f275cc13cd504b968ef22bba935f5854,

title = "F-18-FDG-PET zur Prim{\"a}rdiagnostik und Dignit{\"a}tsbeurteilung pleuraler Prozesse",

abstract = "PURPOSE: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) has been shown to be accurate for differentiating benign from malignant pulmonary lesions. Therefore, we evaluated the capability of FDG-PET in the characterisation of pleural lesions.PATIENTS AND METHODS: PET was performed in thirteen patients with pleural or intrapulmonal tumors (three with additional pleural effusion) and in three patients with aetiologically unclear pleural effusion demonstrated by CT. In all cases the diagnosis was confirmed histologically. The PET-imaging was carried out in fasted patients 50 minutes after injection of 400-670 MBq F-18-FDG without attenuation correction.RESULTS: Twelve patients were found to have pleural or pulmonal malignomas (9 pleural mesotheliomas, 3 bronchogenic adenocarcinoma with carcinomatous pleurisy). Four patients had benign pleural changes (1 fibroma, 1 tuberculous pleurisy, 1 pleural fibrosis, 1 empyema). With FDG-PET, all 12 pleural or intrapulmonal malignomas had high FDG-uptake and were classified correctly. Due to very low or virtually deficient FDG-uptake, four histologically benign lesions were correctly interpreted as nonmalignant.CONCLUSION: These preliminary results suggest that FDG-PET is accurate in detecting malignant pleural tumors.",

author = "I Buchmann and Guhlmann, \{C A\} and K Elsner and W Gfr{\"o}rer and H Schirrmeister and J Kotzerke and A Buck and Reske, \{S N\}",

year = "1999",

language = "Deutsch",

volume = "38",

pages = "319--22",

journal = "NuklearMedizin",

issn = "0029-5566",

publisher = "Georg Thieme Verlag",

number = "8",

}

TY - JOUR

T1 - F-18-FDG-PET zur Primärdiagnostik und Dignitätsbeurteilung pleuraler Prozesse

AU - Buchmann, I

AU - Guhlmann, C A

AU - Elsner, K

AU - Gfrörer, W

AU - Schirrmeister, H

AU - Kotzerke, J

AU - Buck, A

AU - Reske, S N

PY - 1999

Y1 - 1999

N2 - PURPOSE: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) has been shown to be accurate for differentiating benign from malignant pulmonary lesions. Therefore, we evaluated the capability of FDG-PET in the characterisation of pleural lesions.PATIENTS AND METHODS: PET was performed in thirteen patients with pleural or intrapulmonal tumors (three with additional pleural effusion) and in three patients with aetiologically unclear pleural effusion demonstrated by CT. In all cases the diagnosis was confirmed histologically. The PET-imaging was carried out in fasted patients 50 minutes after injection of 400-670 MBq F-18-FDG without attenuation correction.RESULTS: Twelve patients were found to have pleural or pulmonal malignomas (9 pleural mesotheliomas, 3 bronchogenic adenocarcinoma with carcinomatous pleurisy). Four patients had benign pleural changes (1 fibroma, 1 tuberculous pleurisy, 1 pleural fibrosis, 1 empyema). With FDG-PET, all 12 pleural or intrapulmonal malignomas had high FDG-uptake and were classified correctly. Due to very low or virtually deficient FDG-uptake, four histologically benign lesions were correctly interpreted as nonmalignant.CONCLUSION: These preliminary results suggest that FDG-PET is accurate in detecting malignant pleural tumors.

AB - PURPOSE: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) has been shown to be accurate for differentiating benign from malignant pulmonary lesions. Therefore, we evaluated the capability of FDG-PET in the characterisation of pleural lesions.PATIENTS AND METHODS: PET was performed in thirteen patients with pleural or intrapulmonal tumors (three with additional pleural effusion) and in three patients with aetiologically unclear pleural effusion demonstrated by CT. In all cases the diagnosis was confirmed histologically. The PET-imaging was carried out in fasted patients 50 minutes after injection of 400-670 MBq F-18-FDG without attenuation correction.RESULTS: Twelve patients were found to have pleural or pulmonal malignomas (9 pleural mesotheliomas, 3 bronchogenic adenocarcinoma with carcinomatous pleurisy). Four patients had benign pleural changes (1 fibroma, 1 tuberculous pleurisy, 1 pleural fibrosis, 1 empyema). With FDG-PET, all 12 pleural or intrapulmonal malignomas had high FDG-uptake and were classified correctly. Due to very low or virtually deficient FDG-uptake, four histologically benign lesions were correctly interpreted as nonmalignant.CONCLUSION: These preliminary results suggest that FDG-PET is accurate in detecting malignant pleural tumors.

M3 - Zeitschriftenaufsätze

C2 - 10615665

SN - 0029-5566

VL - 38

SP - 319

EP - 322

JO - NuklearMedizin

JF - NuklearMedizin

IS - 8

ER -

F-18-FDG-PET zur Primärdiagnostik und Dignitätsbeurteilung pleuraler Prozesse

Abstract

UN SDGs

Fingerprint

Cite this